de Zeeuw D - Search Results

1

Atrial natriuretic peptide-induced decreases in renal blood flow in man: implications for the natriuretic mechanism.

Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Clin Sci (Lond). 1989 Jul;77(1):55-60. doi: 10.1042/cs0770055. Clin Sci (Lond). 1989. PMID: 2527107

2

Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.

Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Hypertension. 1992 Jul;20(1):80-4. doi: 10.1161/01.hyp.20.1.80. Hypertension. 1992. PMID: 1535613

3

Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.

Heeg JE, de Jong PE, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Clin Sci (Lond). 1991 Sep;81(3):367-72. doi: 10.1042/cs0810367. Clin Sci (Lond). 1991. PMID: 1655338 Clinical Trial.

4

Lisinopril in hypertensive patients with renal function impairment.

de Jong PE, Apperloo AJ, Heeg JE, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. Nephron. 1990;55 Suppl 1:43-8. doi: 10.1159/000186034. Nephron. 1990. PMID: 2161083

5

Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans.

Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Hypertension. 1989 Jun;13(6 Pt 1):640-6. doi: 10.1161/01.hyp.13.6.640. Hypertension. 1989. PMID: 2525524

6

Effect of human atrial natriuretic peptide on blood pressure after sodium depletion in essential hypertension.

Janssen WM, de Jong PE, van der Hem GK, de Zeeuw D. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Br Med J (Clin Res Ed). 1986 Aug 9;293(6543):351-3. doi: 10.1136/bmj.293.6543.351. Br Med J (Clin Res Ed). 1986. PMID: 2942219 Free PMC article.

7

Is the antiproteinuric effect of dipyridamole hemodynamically mediated?

de Jong PE, van der Meer J, van der Hem GK, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. Nephron. 1988;50(4):292-4. doi: 10.1159/000185190. Nephron. 1988. PMID: 3070413

8

Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handling.

Janssen WM, Beekhuis H, de Bruin R, de Jong PE, de Zeeuw D. Janssen WM, et al. Among authors: de jong pe, de zeeuw d, de bruin r. Am J Physiol. 1995 Oct;269(4 Pt 2):F571-80. doi: 10.1152/ajprenal.1995.269.4.F571. Am J Physiol. 1995. PMID: 7485544

9

Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.

van Paassen P, de Zeeuw D, de Jong PE. van Paassen P, et al. Among authors: de jong pe, de zeeuw d. J Cardiovasc Pharmacol. 1995 Jul;26(1):39-45. doi: 10.1097/00005344-199507000-00007. J Cardiovasc Pharmacol. 1995. PMID: 7564363 Clinical Trial.

10

Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.

Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. J Hypertens. 1994 Apr;12(4):439-47. J Hypertens. 1994. PMID: 8064168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters